港股公告掘金 | 藥明生物(02269)發盈喜預期上半年歸屬於公司權益股東的利潤同比增長約56%

智通財經

07-24

【重大事項】：

開拓藥業-B(09939)：KX- 826 酊1.0%治療中國成年男性雄激素脫髮關鍵性臨牀試驗II期階段達到主要終點

訊飛醫療科技(02506)榮獲Wind ESG評級A級

瑞和數智(03680)正式佈局Web3.0和加密貨幣資產領域

元徵科技(02488)：不尋常股價波動預計中期淨利潤不低於1.9億元

【財務數據】：

浙江滬杭甬(00576)：浙商證券(601878.SH)上半年歸母淨利潤11.49億元同比增長46.54%

藥明生物(02269)發盈喜預期上半年歸屬於公司權益股東的利潤同比增長約56%

中國石油化工股份(00386)上半年油氣當量產量約2.63億桶同比增長2%

IMAX CHINA(01970)發佈中期業績，淨利潤2389.3萬美元，同比增加88.9%

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2553789227"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553789227\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2553789227?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-07-24 23:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553789227","market":"us","top_or_hot":-1,"title":"港股公告掘金 | 藥明生物(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%","media":"智通財經","content":"<html><body><p><strong>【重大事項】：</strong></p><p><a href=\"https://laohu8.com/S/09939\">開拓藥業-B</a>(09939)：KX- 826 酊1.0%治療中國成年男性雄激素脫髮關鍵性臨牀試驗II期階段達到主要終點</p><p><a href=\"https://laohu8.com/S/02506\">訊飛醫療科技</a>(02506)榮獲Wind ESG評級A級</p><p><a href=\"https://laohu8.com/S/03680\">瑞和數智</a>(03680)正式佈局Web3.0和加密貨幣資產領域</p><p><a href=\"https://laohu8.com/S/02488\">元徵科技</a>(02488)：不尋常股價波動 預計中期淨利潤不低於1.9億元</p><p><strong>【財務數據】：</strong></p><p><a href=\"https://laohu8.com/S/00576\">浙江滬杭甬</a>(00576)：<a href=\"https://laohu8.com/S/601878\">浙商證券</a>(601878.SH)上半年歸母淨利潤11.49億元 同比增長46.54%</p><p><a href=\"https://laohu8.com/S/02269\">藥明生物</a>(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%</p><p><a href=\"https://laohu8.com/S/00386\">中國石油化工股份</a>(00386)上半年油氣當量產量約2.63億桶 同比增長2%</p><p><a href=\"https://laohu8.com/S/01970\">IMAX CHINA</a>(01970)發佈中期業績，淨利潤2389.3萬美元，同比增加88.9%</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 藥明生物(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 藥明生物(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通財經</strong><span class=\"h-time small\">2025-07-24 23:00</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p><strong>【重大事項】：</strong></p><p><a href=\"https://laohu8.com/S/09939\">開拓藥業-B</a>(09939)：KX- 826 酊1.0%治療中國成年男性雄激素脫髮關鍵性臨牀試驗II期階段達到主要終點</p><p><a href=\"https://laohu8.com/S/02506\">訊飛醫療科技</a>(02506)榮獲Wind ESG評級A級</p><p><a href=\"https://laohu8.com/S/03680\">瑞和數智</a>(03680)正式佈局Web3.0和加密貨幣資產領域</p><p><a href=\"https://laohu8.com/S/02488\">元徵科技</a>(02488)：不尋常股價波動 預計中期淨利潤不低於1.9億元</p><p><strong>【財務數據】：</strong></p><p><a href=\"https://laohu8.com/S/00576\">浙江滬杭甬</a>(00576)：<a href=\"https://laohu8.com/S/601878\">浙商證券</a>(601878.SH)上半年歸母淨利潤11.49億元 同比增長46.54%</p><p><a href=\"https://laohu8.com/S/02269\">藥明生物</a>(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%</p><p><a href=\"https://laohu8.com/S/00386\">中國石油化工股份</a>(00386)上半年油氣當量產量約2.63億桶 同比增長2%</p><p><a href=\"https://laohu8.com/S/01970\">IMAX CHINA</a>(01970)發佈中期業績，淨利潤2389.3萬美元，同比增加88.9%</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://www.zhitongcaijing.com/content/detail/1321721.html\">智通財經</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0039217434.USD","symbol_name":"HSBC GIF CHINESE EQUITY \"AD\" INC","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1321721.html","article_id":"2553789227","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553789227","pubTimestamp":1753369212,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【重大事項】：開拓藥業-B(09939)：KX- 826 酊1.0%治療中國成年男性雄激素脱髮關鍵性臨牀試驗II期階段達到主要終點訊飛醫療科技(02506)榮獲Wind ESG評級A級瑞和數智(03680)正式佈局Web3.0和加密貨幣資產領域元徵科技(02488)：不尋常股價波動 預計中期淨利潤不低於1.9億元【財務數據】：浙江滬杭甬(00576)：浙商證券(601878.SH)上半年歸母淨利潤","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0140636845.USD":"施罗德大中华区股票A Acc","BK1161":"生物科技","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","BK1515":"抗疫概念","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","LU0823426308.USD":"法巴中国股票基金","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","LU1051769294.HKD":"BGF EMERGING MARKETS EQUITY INCOME \"A6\"(HKDHDG) INC","02269":"药明生物","LU1188198961.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) INC QV","LU0173614495.USD":"富达中国焦点A","LU0287142896.SGD":"Fidelity China Focus A-SGD","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","09939":"开拓药业-B","LU0244354667.USD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU0819121731.USD":"HSBC GIF MANAGED SOLUTIONS ASIA FOCUSED GROWTH \"AC\" (USD) ACC","LU1282651048.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (USD) INC","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","LU0181495838.USD":"施罗德新兴亚洲A Acc","HSCEI":"国企指数","00386":"中国石油化工股份","LU1831875114.USD":"SCHRODER ISF ALL CHINA EQUITY \"A\" (USD) ACC","YANG":"三倍做空富时中国ETF-Direxion","BK1589":"北水核心资产","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","HSTECH":"恒生科技指数","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1141":"生命科学工具和服务","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK1610":"ETF&股票定投概念","LU0463099449.HKD":"SCHRODER ISF CHINA OPPORTUNITIES \"A\" (HKD) ACC","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD"},"translate_title":"Hong Kong Stock Announcement Nuggets | WuXi Biologics (02269) issued a profit announcement, expecting profits attributable to the company's equity shareholders to increase by approximately 56% year-on-year in the first half of the year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00386":0.9,"02269":1,"09939":0.9,"HSCEI":1,"HSTECH":1,"YANG":1},"content_text":"【重大事項】：開拓藥業-B(09939)：KX- 826 酊1.0%治療中國成年男性雄激素脱髮關鍵性臨牀試驗II期階段達到主要終點訊飛醫療科技(02506)榮獲Wind ESG評級A級瑞和數智(03680)正式佈局Web3.0和加密貨幣資產領域元徵科技(02488)：不尋常股價波動 預計中期淨利潤不低於1.9億元【財務數據】：浙江滬杭甬(00576)：浙商證券(601878.SH)上半年歸母淨利潤11.49億元 同比增長46.54%藥明生物(02269)發盈喜 預期上半年歸屬於公司權益股東的利潤同比增長約56%中國石油化工股份(00386)上半年油氣當量產量約2.63億桶 同比增長2%IMAX CHINA(01970)發佈中期業績，淨利潤2389.3萬美元，同比增加88.9%","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}